175 related articles for article (PubMed ID: 22709876)
21. Clinical significance and prediction factors of gastric varices in patients with hepatocellular carcinoma.
Yeh JL; Peng YC; Tung CF; Yang DY; Hu WH; Chow WK; Yeh HZ; Chen GH
Hepatogastroenterology; 2003; 50(53):1603-8. PubMed ID: 14571795
[TBL] [Abstract][Full Text] [Related]
22. Adding variceal status to Child-Turcotte-Pugh score improves its performance in predicting early mortality in cirrhosis: the Child-Turcotte-Pugh-Kumar score.
Kumar A; Sharma P; Sarin SK
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1348-9. PubMed ID: 23022921
[No Abstract] [Full Text] [Related]
23. Percutaneous transhepatic portal vein stent placement can improve prognosis for hepatocellular carcinoma patients with portal vein tumor thrombosis.
Ishikawa T; Kubota T; Abe H; Nagashima A; Hirose K; Togashi T; Seki K; Honma T; Yoshida T; Kamimura T
Hepatogastroenterology; 2014; 61(130):413-6. PubMed ID: 24901152
[TBL] [Abstract][Full Text] [Related]
24. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
25. Portal venous tumor growth-type of hepatocellular carcinoma without liver parenchyma tumor nodules: a case report.
Saito M; Seo Y; Yano Y; Uehara K; Hara S; Momose K; Hirano H; Yokozaki H; Yoshida M; Azuma T
Ann Hepatol; 2013; 12(6):969-73. PubMed ID: 24114829
[TBL] [Abstract][Full Text] [Related]
26. Treatment of bleeding esophageal varices with cyanoacrylate and polidocanol, or polidocanol alone: results of a prospective study in an unselected group of patients with cirrhosis of the liver.
Lux G; Retterspitz M; Stabenow-Lohbauer U; Langer M; Altendorf-Hofmann A; Bozkurt T
Endoscopy; 1997 May; 29(4):241-6. PubMed ID: 9255525
[TBL] [Abstract][Full Text] [Related]
27. Gastric metastasis of hepatocellular carcinoma via a possible existing retrograde hematogenous pathway.
Hu ML; Tai WC; Chuah SK; Chiu YC; Wu KL; Chou YP; Kuo CM; Hu TH; Chiu KW
J Gastroenterol Hepatol; 2010 Feb; 25(2):408-12. PubMed ID: 19929932
[TBL] [Abstract][Full Text] [Related]
28. Portal vein thrombosis.
Basit SA; Stone CD; Gish R
Clin Liver Dis; 2015 Feb; 19(1):199-221. PubMed ID: 25454305
[TBL] [Abstract][Full Text] [Related]
29. Hypoxic hepatitis occurring in cirrhosis after variceal bleeding: still a lethal disease.
Amitrano L; Guardascione MA; Martino R; Manguso F; Menchise A; Balzano A
J Clin Gastroenterol; 2012 Aug; 46(7):608-12. PubMed ID: 22772740
[TBL] [Abstract][Full Text] [Related]
30. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
Cheng S; Chen M; Cai J;
Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
[TBL] [Abstract][Full Text] [Related]
31. [Upper digestive hemorrhage in liver cirrhosis: clinical and endoscopic findings].
Fassio E; Viudez P; Landeira G; Fernández N; Lattanzi M; Luis A
Acta Gastroenterol Latinoam; 1992; 22(3):181-6. PubMed ID: 1341118
[TBL] [Abstract][Full Text] [Related]
32. Controversies and certitudes on the upper digestive hemorrhage through rupture of esophageal varices. I. Pathophysiology of portal hypertension and mechanism of rupture of the esophageal varices.
Voiculescu M
Med Interne; 1988; 26(3):179-90. PubMed ID: 3055241
[TBL] [Abstract][Full Text] [Related]
33. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
Peng ZW; Guo RP; Zhang YJ; Lin XJ; Chen MS; Lau WY
Cancer; 2012 Oct; 118(19):4725-36. PubMed ID: 22359112
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
[TBL] [Abstract][Full Text] [Related]
35. Laparoscopic splenectomy for variceal bleeding with non-cirrhotic portal vein thrombosis: a case report.
Tsukamoto T; Ikuta T; Uenishi T; Shuto T; Tanaka H; Kubo S; Hirohashi K; Kinoshita H
Hepatogastroenterology; 2003; 50(50):574-6. PubMed ID: 12749276
[TBL] [Abstract][Full Text] [Related]
36. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M
Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752
[TBL] [Abstract][Full Text] [Related]
37. Prevention of variceal recurrence, bleeding, and death in cirrhosis patients with hypersplenism, especially those with severe thrombocytopenia.
Ohmoto K; Yamamoto S
Hepatogastroenterology; 2003; 50(54):1766-9. PubMed ID: 14696400
[TBL] [Abstract][Full Text] [Related]
38. MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices.
Amitrano L; Guardascione MA; Bennato R; Manguso F; Balzano A
J Hepatol; 2005 Jun; 42(6):820-5. PubMed ID: 15885352
[TBL] [Abstract][Full Text] [Related]
39. Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients.
Hori S; Takaki A; Okada H; Fujiwara A; Takenaka R; Makidono C; Shiratori Y
J Gastroenterol Hepatol; 2006 Nov; 21(11):1704-9. PubMed ID: 16984593
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of endoscopic variceal ligation for bleeding esophageal varices in patients with tumor thrombus of the portal vein trunk (Vp3) associated with hepatocellular carcinoma.
Kokubu S; Matsumoto Y; Murakami M; Shibata H; Saigenji K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-139-S6-142. PubMed ID: 9151930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
